Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Aramchol meglumine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Galmed Pharmaceuticals & VCU Collab on Drug Resistance GI Cancer
    Galmed Pharmaceuticals & VCU Collab on Drug Resistance GI Cancer

    17 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/galmed-pharmaceuticals-launches-vcu-collaboration-to-tackle-drug-resistance-in-gi-cancers-302431484.html

    PR NEWSWIRE
    17 Apr 2025
    Share Share
    Galmed Reveals New Blood Markers for Aramchol, Advanced SCD1 Inhi
    Galmed Reveals New Blood Markers for Aramchol, Advanced SCD1 Inhi

    15 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/galmed-unveils-novel-pharmacodynamic-blood-markers-for-aramchol-the-most-clinically-advanced-scd1-inhibitor-302428834.html

    PR NEWSWIRE
    15 Apr 2025
    Share Share
    Galmed Pharmaceuticals Extends Aramchol Patent Protection to 2039
    Galmed Pharmaceuticals Extends Aramchol Patent Protection to 2039

    20 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/galmed-pharmaceuticals-secures-new-patent-grant-extending-aramchols-patent-protection-to-2039-strengthening-leadership-in-nashmash-combination-therapy-302407043.html

    PR NEWSWIRE
    20 Mar 2025
    Share Share
    Galmed reports results from ARMOR study showing improvements
    Galmed reports results from ARMOR study showing improvements

    04 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/galmed-reports-results-from-the-open-label-part-of-the-armor-study-showing-improvements-in-histology-imaging-and-biomarkers-with-aramchol-301713284.html

    PR NEWSWIRE
    04 Jan 2023
    Share Share
    Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in Lung Fibrosis
    Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in Lung Fibrosis

    07 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/galmed-reports-significant-anti-fibrotic-effects-of-aramchol-in-a-lung-fibrosis-model-301582307.html

    PRNEWSWIRE
    07 Jul 2022
    Share Share
    Galmed Continues to Drive Innovation with 3 New US Patents Granted for Aramchol
    Galmed Continues to Drive Innovation with 3 New US Patents Granted for Aramchol

    11 Jan 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/galmed-continues-to-drive-innovation-with-three-new-us-patents-granted-for-aramchol-and-its-meglumine-salt-301458242.html

    PRNEWSWIRE
    11 Jan 2022
    Share Share